The gap between doctors pay in the public and private sectors is rising steeply, according to international recruitment agencies. In some cases doctors are getting almost twice as much in the latter.
Many emerging market hospital groups seem a hot ticket at the moment. They have the stability which comes with hospitals, married to far more growth than you might expect in Europe, but the workforce war is making investors think twice. HBI speaks to two experts to learn more about how in-house training is proving to be a solution to workforce woes.
Global renal disease specialist Fresenius Medical Care has parted ways with its new CEO just months after announcing her appointment, and scarcely two months after she took up her post. HBI looks at the surprisingly quick turnaround and tries to work out what happened.
In April last year, medical device giant Siemens Healthineers acquired Varian Medical Systems in one of the largest all cash MedTech transactions in history. HBI catches up with Varian CEO Chris Toth to find out more about the deal, and Varian’s plans for the future.
HBI chats with Arjan Toor, CEO of Cigna Europe, about innovation in the insurance market against a backdrop of the pandemic, and a growing crisis in mental health.
The number of ransomware attacks targeting the healthcare sector is increasing exponentially. Multiple recent surveys have found that it is now one of the most targeted sectors of the economy, with as many as one in three of the world’s healthcare organisations being targeted in 2020. This poses a major threat not just to healthcare organisations' finances but also lives. We speak to two cybersecurity experts to find out what healthcare operators can do to protect themselves and their patients.
No listed health care group in Europe has grown anything like as fast as Atrys Health, which now spans Spain, Portugal, Switzerland and four Latin American countries. But does its M&A strategy have any coherence? We talk to Atrys CFO Josep Maria Huch.
Fresenius Helios plans to become the first and only global health care service player by rolling out its Curalie telehealth plus a prefab diagnostic unit (the Cube) starting in Vietnam in October. Deals are being struck with governments in Ghana and Kenya for the group to offer primary care for €10 per cap. to millions. We talk to Fresenius Helios CEO Franceso de Meo.
As Germany-based healthcare conglomerate Fresenius looks to simplify the group's structure, selling off non-core parts of a business which currently spans hospitals, dialysis, pharma, rehabilitation and more, it is building a $2.4bn new business partnership in the US. We speak to an EU-based source familiar with Fresenius to put this all in context.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
